KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)

KMPHARMACEUTICAL Statistics

Total Valuation

KOSDAQ:225430 has a market cap or net worth of KRW 13.11 billion. The enterprise value is 30.22 billion.

Market Cap	13.11B
Enterprise Value	30.22B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:225430 has 5.58 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	5.58M
Shares Outstanding	5.58M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	-0.29%
Owned by Insiders (%)	39.32%
Owned by Institutions (%)	n/a
Float	3.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.80
PB Ratio	0.48
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.60
EV / Sales	1.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.26

Financial Position

The company has a current ratio of 0.27, with a Debt / Equity ratio of 0.62.

Current Ratio	0.27
Quick Ratio	0.15
Debt / Equity	0.62
Debt / EBITDA	n/a
Debt / FCF	-4.68
Interest Coverage	-6.09

Financial Efficiency

Return on equity (ROE) is -13.43% and return on invested capital (ROIC) is -8.39%.

Return on Equity (ROE)	-13.43%
Return on Assets (ROA)	-4.78%
Return on Invested Capital (ROIC)	-8.39%
Return on Capital Employed (ROCE)	-12.03%
Weighted Average Cost of Capital (WACC)	1.65%
Revenue Per Employee	282.40M
Profits Per Employee	-68.59M
Employee Count	58
Asset Turnover	0.34
Inventory Turnover	5.62

Taxes

In the past 12 months, KOSDAQ:225430 has paid 83.75 million in taxes.

Income Tax	83.75M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.33% in the last 52 weeks. The beta is -0.75, so KOSDAQ:225430's price volatility has been lower than the market average.

Beta (5Y)	-0.75
52-Week Price Change	-33.33%
50-Day Moving Average	2,646.00
200-Day Moving Average	2,902.80
Relative Strength Index (RSI)	46.39
Average Volume (20 Days)	787,665

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:225430 had revenue of KRW 16.38 billion and -3.98 billion in losses. Loss per share was -142.23.

Revenue	16.38B
Gross Profit	3.91B
Operating Income	-3.70B
Pretax Income	-3.89B
Net Income	-3.98B
EBITDA	-2.76B
EBIT	-3.70B
Loss Per Share	-142.23

Balance Sheet

The company has 12.37 million in cash and 17.13 billion in debt, with a net cash position of -17.12 billion or -3,068.68 per share.

Cash & Cash Equivalents	12.37M
Total Debt	17.13B
Net Cash	-17.12B
Net Cash Per Share	-3,068.68
Equity (Book Value)	27.43B
Book Value Per Share	986.59
Working Capital	-11.86B

Cash Flow

In the last 12 months, operating cash flow was -3.13 billion and capital expenditures -524.71 million, giving a free cash flow of -3.66 billion.

Operating Cash Flow	-3.13B
Capital Expenditures	-524.71M
Depreciation & Amortization	938.07M
Net Borrowing	2.33B
Free Cash Flow	-3.66B
FCF Per Share	-656.07

Margins

Gross margin is 23.85%, with operating and profit margins of -22.59% and -24.29%.

Gross Margin	23.85%
Operating Margin	-22.59%
Pretax Margin	-23.77%
Profit Margin	-24.29%
EBITDA Margin	-16.86%
EBIT Margin	-22.59%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:225430 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	-0.02%
Earnings Yield	-30.35%
FCF Yield	-27.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 14, 2026. It was a reverse split with a ratio of 0.2.

Last Split Date	Apr 14, 2026
Split Type	Reverse
Split Ratio	0.2

Scores

KOSDAQ:225430 has an Altman Z-Score of 0.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.67
Piotroski F-Score	3